View More Recent Stories
-
argenx (ARGX) Tops Q3 EPS by 124c
-
Raymond James Resumes argenx SE (ARGX) at Strong Buy
-
Piper Sandler Reiterates Overweight Rating on argenx SE (ARGX)
-
Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
-
Piper Sandler Reiterates Overweight Rating on argenx SE (ARGX)
-
Baird Reiterates Outperform Rating on argenx SE (ARGX)
-
Eight defensive growth stocks to own right now
-
Barclays Upgrades argenx SE (ARGX:BB) (ARGX) to Overweight
-
argenx SE (ARGX) PT Raised to $515 at Baird
-
argenx SE (ARGX) PT Raised to $533 at H.C. Wainwright
-
argenx SE (ARGX) PT Raised to $547 at Wells Fargo
-
argenx (ARGX) Tops Q2 EPS by 135c; offers guidance
-
Oppenheimer Upgrades argenx SE (ARGX) to Outperform
-
argenx SE (ARGX) PT Raised to $540 at Truist Securities
-
argenx SE (ARGX) PT Raised to $504 at H.C. Wainwright
-
Scotiabank Reiterates Sector Perform Rating on argenx SE (ARGX)
-
Barclays Reiterates Equalweight Rating on argenx SE (ARGX:BB) (ARGX)
-
argenx SE (ARGX) PT Raised to $490 at H.C. Wainwright
-
argenx SE (ARGX) PT Raised to $512 at Citi
-
argenx SE (ARGX) PT Raised to $480 at Truist Securities
-
TD Cowen Reiterates Buy Rating on argenx SE (ARGX)
-
argenx SE (ARGX) PT Raised to $542 at Wells Fargo
-
argenx SE (ARGX) PT Raised to $535 at Piper Sandler
-
argenx SE (ARGX) PT Raised to $416 at Scotiabank
-
H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
-
argenx SE (ARGX) PT Raised to $500 at Stifel
-
argenx (ARGX) Announces FDA Approval of VYVGART Hytrulo
-
Barclays Reiterates Equalweight Rating on argenx SE (ARGX:BB) (ARGX)
-
Piper Sandler Reiterates Overweight Rating on argenx SE (ARGX)
-
H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)

